References
- Isbister GK, Bawaskar HS. Scorpion envenomation. N Engl J Med. 2014;371(5):1–6.
- LoVecchio F, McBride C. Scorpion envenomations in young children in Central Arizona. J Toxicol Clin Toxicol. 2003;41(7):937–940.
- Darracq MA, Clark RF. Antivenom: scorpion. In: Nelson LS, Howland M, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank’s toxicologic emergencies, 11th ed. New York City: McGraw Hill; 2019.
- Abroug F, Ouanes-Besbes L, Tilouche N, et al. Scorpion envenomation: state of the art. Intensive Care Med. 2020;46(3):401–410. Mar
- Quan D, LoVecchio F, Bhattarai B, et al. Comparing clinical outcomes between two scorpion antivenom dosing strategies in children. Clin Toxicol (Phila). 2019;57(9):760–764.
- Rachesky I, Banner W, Dansky J, et al. Treatments for centruroides exilicauda envenomation. Am J Dis Child. 1984; 138(12):1136–1139.
- Boyer L. History of scorpion antivenom: one arizonan’s view. Toxicon. 2013;69:14–20.
- Gibly R, Williams M, Walter FG, et al. Continuous intravenous midazolam infusion for centruroides exilicauda scorpion envenomation. Ann Emerg Med. 1999; 34(5):620–625.
- D’Suze G, Corzo Burguete GA, Paniagua Solis JF. Emergencias por animals ponsoñosos en las américas. Mexico: bioclon Institute; 2003. Alacranismo en león, Guanajuato, méxico; p. 15–30.
- Likes K Banner, W, Jr, Chavez M. Centruroides exilicauda envenomation in Arizona. West J Med. 1984; Nov141(5):634–637.
- Anascorp. Package insert. Instituto Bioclon S.A. de C.V; 2011.
- Boyer LV, Theodorou AA, Berg RA, Arizona Envenomation Investigators, et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. 2009 May 14;360(20):2090–2098.
- Boyer L, Theodorou A, Chase P, et al. Effectiveness of centruroides scorpion antivenom compared to historical controls. Toxicon. 2013;76:377–385. 15
- Sinha M, Quan D, McDonald FW, et al. Cost minimization analysis of different strategies of management of clinically significant scorpion envenomation among pediatric patients. Pediatr Emerg Care. 2016;32(12):856–862.
- Vazquez H, Chavez-Haro A, Garcia-Ubbelohde W, et al. Pharmacokinetics of F(ab’)2 scorpion antivenom administered intramuscularly in healthy human volunteers. Int Immunopharmacol. 2010;10(11):1318–1324. Nov
- Vazquez H, Chavez-Haro A, Garcia-Ubbelohde W, et al. Pharmacokinetics of F(ab’)2 scorpion antivenom in healthy human volunteers. Toxicon. 2005;46(7):797–805. Dec 1
- Boyer L, Degan J, Ruha AM, et al. Safety of intravenous equine F (ab’) 2: insights following clinical trials involving 1534 recipients of scorpion antivenom. Toxicon. 2013;76:386–393. 15
- Klotz SA, Yates S, Smith SL, et al. Scorpion stings and antivenom use in Arizona. Am J Med. 2021;134(8):1034–1038.
- Coorg V, Levitan RD, Gerkin RD, et al. Clinical presentation and outcomes associated with different treatment modalities for pediatric bark scorpion envenomation. J Med Toxicol. 2017;13(1):66–70.